Patent applications published 29 September 2010
Selected patent applications from the weekly European Patents Bulletin
- Nanoparticulate anidulafungin compsns and methods for making the same
Elan Pharma 2230906*
- Benzylphenyl cyclohexane derivatives and methods of use
Teracos 2230907*
- Treatment with melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (HSAA)
Sciclone Pharmaceuticals 2230908*
- Pre-surgical treatment
Galderma Laboratories 2230909*
- Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs
ZARS Pharma 2230911*
- Pyrazolone derivative emulsion formulations
Teikoku Pharma; Techno Guard 2230912*
- Pharmaceutical compound for the prophylaxis and/or symptomatic treatment of cystic fibrosis
Cycnad 2231113*
- Compsn for the treatment of a detached retina and method of production thereof
Ulive Enterprises 2231114*
- Transcutaneous pharmaceutical compsns containing a steroid hormone
Pierre Fabre Medicament 2231115*
- Pharmaceutical formulations containing tolperisone
Richter Gedeon 2231116*
- Benzodiazepine and/or pharmaceutical compsn comprising benzodiazepine derivatives
Gesellschaft für Medizinische Forschung und Weiterbildung 2231117*
- Suspension comprising non-micronised ezetimibe micro-particles
KRKA 2231118*
- Pharmaceutical foams
Monteresearch-Pharmaceutical Development Service 2231119*
- Solid lipid microcapsules containing growth hormone in the inner solid core
Merck Patent 2231120*
- Pharmaceutical compsns
Karo Bio 2231121*
- Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
Evonik Röhm 2231122*
- Methods and compsns for oral administration of protein and peptide therapeutic agents
Oshadi Drug Administration 2231123*
- Sustained-release pharmaceutical formulation containing an anti-muscarinic agent and a wetting agent as well as a process for the preparation thereof
Pharmathen 2231124*
- Manufacturing solid pharmaceutical dosage forms with visible micro- and nanostructured surfaces and micro- and nanostructured pharmaceutical dosage form
I-Property Holding Corp 2231125*
- Oral dispersible tablet
Bayer Schering Pharma 2231126*
- Method of treating dysglycaemia and glucose excursions
MacGregor, Alexander 2231128*
- Therapeutic regimens for the treatment of immunoinflammatory disorders
Combinatorx 2231129*
- Formulations comprising exine shells
University of Hull 2231130*
- Formulations of organo-paltinic compounds in the presence of associative polymers, products thus obtained and uses thereof
Coatex 2231131*
- Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
Université Victor Segalen Bordeaux; Université de Bourgogne; Université de la Méditerranée 2231132*
- Method and compsns for administering resveratrol and pterostilbene
Rubin, David; Rubin, Tal 2231133*
- Biocompatible and biodegradable biopolymer matrix
Indo-French Centre for the Promotion of Advanced Research 2231134*
- Compounds for preventing and treating plasmodium infections
Universite Pierre et Marie Curie; Université Paris Diderot; Universidad de Valencia; Assistance Publique - Hôpitaux de Paris 2231135*
- Compsns comprising hydroxy-tyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
DSM IP Assets 2231136*
- Method of modulating membrane potential of a cell
Yang, Dan; Li, Xiang; Shen, Bing; Yao, Xiao-qiang; The Chinese University of Hong Kong; Versitech 2231137*
- Oral pharmaceutical suspension comprising paracetamol and ibuprofen
Wockhardt Research Centre; Aft Pharmaceuticals; Atkinson, Hartley; Kiely, Austin 2231138*
- Therapeutic formulations based on asiatic acid and selected salts thereof
Shanghai Institute of Pharmaceutical Industry 2231139*
- Sigma ligands and IKK/NF-KB inhibitors for medical treatment
University of Dundee 2231140*
- Compsns and methods for increasing muscle mass, strength, and functional performance in the elderly
HealthSpan Solutions 2231141*
- Methods of and combination therapies for treating or delaying the onset of dyskinesia
Fisone, Gilberto; Valjent, Emmanuel; Santini, Emanuela 2231142*
- Inhibitors of janus kinases
Merck Sharp & Dohme 2231143*
- Nanodispersion
Sun Pharma Advanced Research 2231144*
- Use of glycosylceramides for enhancing the immune response to antigens
Wittycell 2231145*
- Pharmaceutical compsn for the treatment and prevention of glaucoma
Mazence; KT & G 2231146*
- Combinations of therapeutic agents for treating cancer
Novartis 2231147*
- Pharmaceutical compsn for the treatment and prevention of cardiac disease
Mazence; KT & G 2231148*
- ALDH-2 inhibitors in the treatment of psychiatric disorders
CV Therapeutics 2231149*
- Method for treating addiction using quercetin-containing compsns
Lines, Thomas Christian 2231150*
- Antifolate compounds for the treatment of melanoma
Universidad de Murcia 2231151*
- Thienopyranones as kinase inhibitors
Park Funding 2231152*
- 5-oxo-3-pyrrrolidinecarboxamide derivatives as P2X7 modulators
Glaxo Group 2231153*
- Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter
H Lundbeck; Takeda Pharmaceuticals North America 2231154*